Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory SyndromeHratch Baghdassarian, Lori Broderick, Sarah A. Blackstone et al.|New England Journal of Medicine|2023Cited by 78
Author response: Histone deacetylase 3 represses cholesterol efflux during CD4+ T-cell activationDrew N. Wilfahrt, Virginia Smith Shapiro, Michael J. Shapiro et al.|Unknown|2021Cited by 0